[HTML][HTML] Fundus-controlled perimetry (microperimetry): application as outcome measure in clinical trials

M Pfau, JK Jolly, Z Wu, J Denniss, EM Lad… - Progress in Retinal and …, 2021 - Elsevier
Fundus-controlled perimetry (FCP, also called 'microperimetry') allows for spatially-resolved
mapping of visual sensitivity and measurement of fixation stability, both in clinical practice as …

It is time for a moonshot to find “Cures” for diabetic retinal disease

SR Levine, P Sapieha, S Dutta, JK Sun… - Progress in Retinal and …, 2022 - Elsevier
Diabetic retinal disease (DRD), the most common complication of diabetes and a leading
cause of blindness in working age individuals, is now understood to be a form of sensory …

Imaging features associated with progression to geographic atrophy in age-related macular degeneration: classification of atrophy meeting report 5

GJ Jaffe, U Chakravarthy, KB Freund, RH Guymer… - Ophthalmology …, 2021 - Elsevier
Purpose To provide an image-based description of retinal features associated with risk for
development of geographic atrophy (GA) in eyes with age-related macular degeneration …

[HTML][HTML] Ultrahigh resolution OCT markers of normal aging and early age-related macular degeneration

S Chen, O Abu-Qamar, D Kar, JD Messinger… - Ophthalmology …, 2023 - Elsevier
Purpose Ultrahigh resolution spectral domain-OCT (UHR SD-OCT) enables in vivo
visualization of micrometric structural markers which differentially associate with normal …

[HTML][HTML] Biologically guided optimization of test target location for rod-mediated dark adaptation in age-related macular degeneration: alabama study on early age …

C Owsley, TA Swain, G McGwin Jr, ME Clark… - Ophthalmology …, 2023 - Elsevier
Purpose We evaluate the impact of test target location in assessing rod-mediated dark
adaptation (RMDA) along the transition from normal aging to intermediate age-related …

Clinical perspectives and trends: microperimetry as a trial endpoint in retinal disease

Y Yang, H Dunbar - Ophthalmologica, 2021 - karger.com
Endpoint development trials are underway across the spectrum of retinal disease. New
validated endpoints are urgently required for the assessment of emerging gene therapies …

Biomarkers for the progression of intermediate age-related macular degeneration

EM Lad, RP Finger, R Guymer - Ophthalmology and Therapy, 2023 - Springer
Age-related macular degeneration (AMD) is a leading cause of severe vision loss
worldwide, with a global prevalence that is predicted to substantially increase. Identifying …

[HTML][HTML] How vision is impaired from aging to early and intermediate age-related macular degeneration: insights from ALSTAR2 baseline

C Owsley, TA Swain, G McGwin… - … Vision Science & …, 2022 - iovs.arvojournals.org
Purpose: We hypothesize the first visual dysfunction in transitioning to early and
intermediate age-related macular degeneration (AMD) is delayed rod-mediated dark …

Discernibility of the interdigitation zone (IZ), a potential optical coherence tomography (OCT) biomarker for visual dysfunction in aging

A Berlin, E Matney, SG Jones, ME Clark… - Current Eye …, 2023 - Taylor & Francis
Purpose Photoreceptor (PR) outer segments, retinal pigment epithelium apical processes,
and inter-PR matrix contribute to the interdigitation zone (IZ) of optical coherence …

[HTML][HTML] Geographic atrophy in age-related macular degeneration: a tale of two stages

TDL Keenan - Ophthalmology Science, 2023 - Elsevier
Purpose To examine disease progression in age-related macular degeneration (AMD) at 2
distinct stages, progression to geographic atrophy (GA) versus GA expansion, by …